If you’re a trainee or early career GI, don’t miss out on these #DDW2024 networking events designed just for you! 🤩 Mark your calendars. ⤵️

🤝🏼 AGA-DHPA trainee & early career networking event (May 19, 2 p.m.)
🤝🏼 AGA trainee + journal editors meetup (May 20, 11 a.m.)

#Re - #resection Rates and #Disease #Re currence in #CD - A Population-Based Study Using Individual-Level Patient Data Anja Poulsen Jakob Seidelin

academic.oup.com/ecco-jcc/advan…

Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis
nature.com/articles/s4159…

Colorectal cancer #CRC in #IBD : a review of the role of gut #microbiota and bacterial #biofilms in disease pathogenesis David A. Muñiz Pedrogo et al.

academic.oup.com/ecco-jcc/advan…

#FMT for #UC from #diet conditioned donors followed by #diet ary intervention results in favorable gut microbial profile compared to #FMT alone Haim Leibovitzh et al. Nathaniel A. Cohen

academic.oup.com/ecco-jcc/advan…

Non-pooled multi-donor #FMT was comparable to placebo in inducing clinical remission in patients with chronic #pouchitis , but it was associated with an increase in adverse events Kousgaard et al. Crohn's & Colitis Foundation
academic.oup.com/ecco-jcc/advan…

Fecal microbiota transplantation is no better than placebo for chronic pouchitis, and had ⬆️ adverse events.

#MedTwitter #GITwitter #IBD #FMT #microbiome

academic.oup.com/ecco-jcc/advan…

A new approach to identify therapeutic targetson Crohn's disease based on MRE findings

Differential efficacy of medical therapies for ulcerative colitis according to disease extent: patient-level analysis from multiple RCTs

The findings underscore possibility of differential efficacy of medical therapies according to disease distribution

thelancet.com/journals/eclin…

🔥 Treatment options for refractory #ulcerative #colitis :
➡️ Small molecules, big effects 🤛

📕 🆕️ editorial in UEGJ ‼️
👉tinyurl.com/5cpt8746

📕 original article:
👉tinyurl.com/ynd76xy3

my_UEG Wiley Clinical Health Jan Král
#GITwitter #IBD Twitter #IBD #myUEGcommunity

2️⃣ Sat May 18, Poster session 12.30-1.30pm #Sa1008

Grab your ☕️🍪 & join the one & only 💎Beatriz Gros presenting her work on #GenderDisparities in authorship of #IBD RCT along w Joseph Sleiman, MD Mehak Bassi, MD (She/her)

⭐️& let’s talk about closing this gender gap together Digestive Disease Week

Long-term outcome of risankizumab in Crohn’s disease: a real-world GETAID study
▶️174 patients exposed >=3 biologics
▶️ steroid-free clinical remission : 47% w26, 46% w52
▶️One year discontinuation : 26% (LOR, 42%; Ir failure, 37%; intolerance, 13%)

cghjournal.org/article/S1542-…

Atypical chemokine receptors in the immune system dlvr.it/T6XrV1

RAHMA ELMAHDI IS THIS YEAR'S JAKOBINER AWARDEE 🏅

We are delighted that this year’s Jakobiner awardee is Dr Red Elmahdi, Associate Professor in Clinical Medicine at PREDICT.

Huge congratulation to Red for fantastic honour! 👏

Danmarks Grundforskningsfond Aalborg Universitet Aalborg Universitetshospital AAU SUND

Apply now for the UEG Clinical Visiting Fellowship program!
Don't miss the chance to spend 2 weeks in Milan 🇮🇹 at the IBD center of Ospedale San Raffaele with Prof. Danese Silvio Danese and all the experts.
➡️ueg.eu/opportunities/…

Thank you my_UEG I’m truly honoured to receive this prestigious price. Y-ECCO Department of Hepatology and Gastroenterology, AUH HealthAU Aarhus Uni.hospital

#Fibrosis -related transcriptome unveils a distinctive remodeling matrix pattern in #penetrating ileal #CD de Sousa et al. Fernando Magro

academic.oup.com/ecco-jcc/advan…

🚨Novel clinical trial methods could improve efficiency of drug development👇🏽 👇👇🏿

Basket, Umbrella and Platform Trials: The Potential for Master Protocol-Based Trials in #IBD
pubmed.ncbi.nlm.nih.gov/38677483/
Gastroenterology
Vipul Jairath MBChB DPhil Silvio Danese Laurent Peyrin-Biroulet Bruce E. Sands

#CGH4ALL CGH

This model outperforms existing📸-based Perianal CD activity indices (MAGNIFI-CD & modified Van Assche MRI scores) for predicting anti-TNF response.

🌟Model:
- PAF Dx Age
- Time to TNFi initiation
- 🚬
- 8 MRI characteristics

🔗doi.org/10.1016/j.cgh.…

Great video and 🗝️ takeaways from Charlie Lees on treatment in #crohnsdisease

InternationalBowelUS #IUS offers an invaluable and patient friendly way of
2) monitoring therapy closely,
3) assess if therapy is not working
4) discover asymptomatic uncontrolled inflammation